On this page:

Evaluating the sterility of your therapeutics for product quality and safety

 

The complexity of cell therapy workflows can significantly increase the risk of contamination, making sterility a critical concern. Contaminants—such as bacteria, fungi, and viruses—pose a patient safety risk and rigorous safety testing ensures compliance with stringent regulatory standards. Discover our fast and highly-sensitive methods for mycoplasma detection and rapid sterility testing.

Read about new analytical strategies for sterility and mycoplasma testing.


Mycoplasma detection

Sensitive, specific, and accurate mycoplasma testing is essential for safeguarding both the manufacturing process and the final product

Testing for mycoplasma in cell therapy manufacturing is required to ensure the safety of these products. Regulatory agencies require sensitive and specific mycoplasma testing methods to ensure compliance with safety and quality standards. The presence of mycoplasma can significantly compromise the quality, safety, and efficacy of the final product, as well as pose serious health risks to patients.

Moreover, contamination during the production process could result in reduced yields and lower quality or functionality leading to batch failure. Through thorough mycoplasma testing, manufacturers can help prevent costly production delays, maintain product integrity, and ensure the delivery of safe, effective therapeutics to patients.


Rapid sterility testing

Monitor your cell therapy workflow by implementing rapid sterility testing

Raw materials and in-process rapid sterility testing in cell therapy manufacturing addresses the need for early and accurate detection of potential microbial contamination. This helps ensure the safety and efficacy of the final product while allowing for efficiency during the manufacturing process.

Traditional methods can take up to 14 days to deliver results. qPCR-based testing functions as a rapid risk assessment tool for detecting bacterial and fungal DNA during the production process, often delivering results in less than 5 hours. This advanced technique enables the detection of potential contaminants with greater sensitivity and speed, thereby helping to improve the overall quality assurance within cell therapy production processes.


Request a technical consultation

No matter your questions, we are here to help. Our experienced team of scientists and technical specialists is ready to assist you in choosing the right solution and products. Complete this form to start the conversation.
 

 


Infographic

Rapid mycoplasma testing: Meeting regulatory requirements with confidence

On-demand webinar

Overcoming challenges in cell therapy production: Rapid sterility testing                             

Application note

Rapid in-process sterility testing for cell therapy products                                                             


Analytics Knowledge Hub


Explore the Analytics Knowledge Hub and discover a robust collection of webinars, articles, eBooks, infographics, and other digital resources to help you optimize analytical testing  in your bioprocess workflow.
 

Additional resources

Enhance your bioprocessing knowledge with educational content to help you understand issues, solve problems, and make solid decisions.

Deep dive into a targeted collection of scientific application notes, case studies, posters, white papers and more for bioprocessing.

Learn, evaluate, connect.


 

 

 

Connect with a Bioprocessing representative or request more info.

 

 


Thermo Fisher Bioprocessing Portfolio

Upstream bioprocessing

Develop and scale biomanufacturing processes efficiently with trusted technologies and full-service support.

 

Downstream bioprocessing

Streamline downstream biomanufacturing and improve product quality with innovative technologies and outsourcing services to drive efficiency.

Assurance of supply

We strive to support industry growth by investing in capacity and quality systems for a reliable supply of critical materials.